It is with great pleasure that we announce the recipients of funding from the fourth round of the
Patrick C. Walsh Prostate Cancer Research Fund. This first round in 2005 was extremely successful
with 40 applications being received. The fourth round had a total of 23 applications submitted. The
review panel spent significant effort reviewing each of the applications. Although we did not have
sufficient funds to support all of the work that was deemed worthy of support, we were able to fund
individuals from diverse backgrounds and research projects. We are greatly anticipating the exciting
applications that will be submitted for the next round later this year. Everyone is encouraged to
apply. In addition to the financial support, we provide assistance with the research project being
pursued. The recipients of the fourth round of support are:
| PI |
Primary Dept |
Title |
Amount |
| Carter, H. Ballentine |
Urology |
Longitudinal Biomarker Studies in Men Managed Expectantly With Prostate Cancer |
48,000 |
| Stoianovici, Dan |
Urology |
MRI ROBOT FOR TARGETING THE PROSTATE |
75,000 |
| DeMarzo, Angelo |
Pathology |
Generation of improved mouse models of prostate cancer |
75,000 |
| Luo, Jun |
Urology |
AGR2 as a molecular target for prostate cancer metastasis precursor cells |
75,000 |
| Netto, George |
Pathology |
Evaluation of the Prognostic Role of TMPRSS2/ETS Fusion Genes using The Johns Hopkins Brady Urological Institute PSA-Era Case-Control Progression Tissue Microarray Set. |
74,835 |
| Burnett, Arthur |
Urology |
Clinical Study of the Effects of Erythropoietin on Erectile Function in Patients Udergoing Bilateral Nerve-Sparing Radical Retropubic Prostatectomy |
75,000 |
| Meeker, Alan |
Pathology |
Specific detection of prostate cancer cells in urine by multiplex immunofluorescence and telomere FISH ￢ﾀﾓ guiding clinical decisions following negative prostate biopsy |
75,000 |
| NEW APPLICATIONS FUNDED |
|
|
|
| Charles Drake |
Oncology |
Exhausted CD8 T Cells In Prostate Cancer |
75,000 |
| William Isaacs |
Urology |
Alpha Methyl AcylCoA Racemase (AMACR) as a Target for Prostate Cancer Therapy and Intraprostatic Imaging |
75,000 |
| Srinivasan Yegnasubramanian |
Oncology |
High-throughput screening for mutations in exons of chromosome 8p in prostate cancers |
75,000 |
| Hui Zhang |
Pathology |
Glycoproteins for Pathologic Prediction of Prostate Cancer |
75,000 |
| Bruce Trock |
Urology |
The Senescent Phenotype in Human Prostate Cancer: Pilot Characterization Study and Association with Aging and Cellular Stress |
75,000 |
| William Nelson |
Oncology |
Epigenetic Regulation of a Cluster of MicroRNAs Targeting c-Myc in Prostate Cancer |
75,000 |
| Marikki Laiho |
Rad Onc and Molecular Radiation Sciences |
Utilization of Prostate Tissue Cultures in Determination of Cellular DNA Damage Response and Drug Responses |
75,000 |
| Edward Schaeffer |
Urology |
The Role of Sox9 in Fibroblast Growth Factor Signaling and Prostate Cancer |
75,000 |
Dr. Patrick Walsh received
the American Urological Association's highest honor, the Ramon Guiteras
Award that is awarded to individuals for "outstanding contributions
to the art and science of urology".
Patrick Walsh receives the
Valentine Medal from the New York Academy of Medicine for his contributions
to the science and art of urology.
Donald S. Coffey receives
an award from the American Urological Association for his lifetime accomplishments
in urology.
